Current Studies

The Office of Research at Saint Peter’s University Hospital is currently managing over 20 different clinical studies.  Of these, here is a sampling of some of the groundbreaking trials that are currently enrolling new patients:
Pfizer 1106, Primary Investigator: Dr. Carlos Lastra
A 12-Month Open-Label Study to Evaluate the Safety and Tolerability of Pregabalin as Adjunctive Therapy in Pediatric Subjects 1 Month to 16 Years of Age With Partial Onset Seizures and Pediatric Adult Subjects 5 to 65 Years of Age With Primary Generalized Tonic-Clonic Seizures
Neurelis, Inc. DIAZ. 001.04, Primary Investigator: Dr. Carlos Lastra
An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions
Celgene MAGNIFY, Primary Investigator: Dr. Sameer Desai
A Phase 3b randomized study of lenalidomide (CC-5013) plus rituximab maintenance therapy followed by lenalidomide singe-agent maintenance versus rituximab maintenance in subjects with  relapsed / refractory follicular, marginal zone or mantle cell lymphoma
Celgene MDS-ALS, Primary Investigator: Dr. Sameer Desai
Connect®MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
Maternal Fetal Medicine
Natera, Inc. SMART, Primary Investigator: Dr. Harumi Jyonouchi
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
Avinger, Inc. VISION, Primary Investigator: Dr. Ramzan Zakir
 EValuatIon of the PantheriS OptIcal COherence Tomography ImagiNg Atherectomy System for use in the Peripheral Vasculature
 A non-randomized, prospective, global clinical trial of the Avinger Pantheris System, an atherectomy device that provides directional visualization and imaging as an adjunct to fluoroscopy to aid removal of plaque in diseased lower extremity arteries.
The Children’s Oncology Group
The Children’s Hospital at Saint Peter’s University Hospital is a member institution of The Children’s Oncology Group (COG).  COG is a group offering clinical trials supported by the National Cancer Institute. It is a collaborative team comprised of 9,000 experts in childhood cancer at more than 200 leading children’s hospitals, universities, and cancer centers across the globe.  This includes locations in North America, Australia, New Zealand, and Europe.
More than 30 clinical trials are currently open through The Children’s Oncology Group. These trials include treatment for many types of pediatric cancers, studies focused on the underlying biology of these diseases, and trials involving supportive care and survivorship.
The Children’s Oncology Group research has helped to turn childhood cancer from a nearly incurable disease 50 years ago to one with a combined 5-year survival rate of 80% today.  The mission is to cure all children and adolescents with cancer, as well as reduce both the short and long-term obstacles of cancer treatments.  Finally, COG wishes to determine the causes, and find ways to prevent, childhood cancer.
If any of these studies interest you, or you would like to learn more, please contact us. 

Subscribe to Our Newsletter

Subscribe to the Saint Peter's Better Health newsletter and receive the latest health news, community events, recipes, and more.

Give to Saint Peter's

Proceeds generated are used to provide assistance for the many capital and operating needs of Saint Peter's University Hospital. Donate TodayLearn More